Work

Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial

Year: 2009

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Lancet

DOI: 10.1016/s0140-6736(09)60333-0

Authors: Marcus B Conde, Anne Efron, Carla Loredo, Gilvan R Muzy De Souza, Nadja P Graça, Michelle C Cezar, Malathi Ram, Mohammad A Chaudhary, William R Bishai, Afranio L Kritski, Richard E Chaisson

Institutions: Universidade Federal do Rio de Janeiro, Hospital Universitário Clementino Fraga Filho, Johns Hopkins University, Johns Hopkins Medicine

Language: English

Topic: Tuberculosis Research and Epidemiology

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, U.S. Food and Drug Administration, U.S. Public Health Service, National Institute of Allergy and Infectious Diseases, Fogarty International Center

Awards: G122526786, Innovative Approaches for TB Control in Brazil, G2300597250, G2482576825, Clinical Research in Tuberculosis

OpenAlex ID: W1965877207

FWCI: 27.7

Cites: 25

Cited by: 294

Related to: 10